DeepMed Research

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli

Recruiting

Conditions: Normal Physiology

First Posted Date: 2015-12-14

Last Posted Date: 2025-05-16

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 2378

Registration Number: NCT02629107

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Phase 1

Recruiting

Conditions: Epilepsy

Interventions: Drug: Mangafodipir

First Posted Date: 2015-08-25

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 40

Registration Number: NCT02531880

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection

Phase 1

Terminated

Conditions: HIV Infections
Neurologic Disorders

First Posted Date: 2015-08-19

Last Posted Date: 2019-11-29

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 1

Registration Number: NCT02527460

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Phase 1

Not yet recruiting

Conditions: Palliative Care
Intractable Pain

Interventions: Drug: Resiniferatoxin

First Posted Date: 2015-08-13

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 30

Registration Number: NCT02522611

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging

Phase 1

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Ferumoxytol

First Posted Date: 2015-07-29

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 14

Registration Number: NCT02511028

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing

Early Phase 1

Completed

Conditions: Healthy Volunteers
Writer's Cramp
Cervical Dystonia

Interventions: Device: TMS

First Posted Date: 2015-07-22

Last Posted Date: 2025-03-05

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 58

Registration Number: NCT02504905

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Natural History of Multiple Sclerosis and Its Mimickers

Completed

Conditions: Healthy Volunteers
Neurologic Disorders
Multiple Sclerosis

First Posted Date: 2015-07-22

Last Posted Date: 2022-10-14

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 104

Registration Number: NCT02504840

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Phase 1

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Darunavir
Drug: Ritonavir
Drug: Dolutegravir
Drug: Tenofovir alafenamide (TAF)

First Posted Date: 2015-05-07

Last Posted Date: 2024-01-09

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 122

Registration Number: NCT02437110

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Inflammatory and Infectious Diseases of the Nervous System

Recruiting

Conditions: Brain Disease

First Posted Date: 2015-05-06

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 1000

Registration Number: NCT02435810

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Oral Guanabenz for Multiple Sclerosis

Phase 1

Terminated

Conditions: Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis

Interventions: Drug: Guanabenz

First Posted Date: 2015-04-22

Last Posted Date: 2019-12-12

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 2

Registration Number: NCT02423083

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy